Unrequited love drove a 57-year-old man to an AI. Delusions of grandeur followed.

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Elden Ring is a vast game that takes you through an enormous world ...

The HBO adaptation of Gillian Flynn's Sharp Objects novel is faithful to the source material in the best way. Some might even argue its few changes make for an improved iteration of the Gone Girl ...

The roots of Russia's invasion of Ukraine go back decades and run deep. The current conflict is more than one country fighting to take over another; it is — in the words of one U.S. official — a shift ...

The ending of Saros remains purposefully ambiguous, prompting you to draw your own conclusions about Arjun's story and the true meaning behind the allegories throughout the game. So what does it all ...

Black holes are regions in space where an enormous amount of mass is packed into a tiny volume. This creates a gravitational pull so strong that not even light can escape. They are created when giant ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...